4,0
30. März 2025
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Supportive and collaborative team Opportunity to work on real-world clinical trial data Good work-life balance Exposure to modern data engineering tools and serverless architecture Clear expectations and timely feedback
Kontras
Limited long-term growth opportunities Slight delays in communication across departments